Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1
about
HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particlesA dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.Protection against establishment of retroviral persistence by vaccination with a live attenuated virus.HIV-1 Transmission, Replication Fitness and Disease Progression.Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memoryA low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat.Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmissionCounteraction of HLA-C-mediated immune control of HIV-1 by Nef.Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.Allergen-specific CD8(+) T cells and atopic disease.The role of unintegrated DNA in HIV infectionEscape from highly effective public CD8+ T-cell clonotypes by HIVViral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variableEffects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus.Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophagesHuman immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1.
P2860
Q28538038-E6EB54A1-E62E-44D0-91B5-B3176759A7C0Q33604871-D038ED5D-1B58-4509-9AFE-A3903743F1FDQ33646493-FB362362-5B76-49CA-8386-62B07C81E2E1Q33758570-32AFF515-D0A0-405F-A971-6906FBCFD88CQ33812709-0ED2457D-C280-4D36-9AEF-8839E265C029Q33815728-5E67672B-FDB1-43C9-889A-E2700AF457E6Q33820285-F5A4563A-EE66-4A56-97E0-9FA32E0A3782Q33835795-BD77F8E3-F73A-4CDC-A157-A58AA11FFA3DQ33839136-3AF58A41-BEE1-488B-8913-2FA224F5B013Q33936741-1E0D3735-8B69-4098-B156-74BD2C6E9450Q33966673-AC4E6AF0-9369-419E-AD6A-C1B3A01ABF26Q34007084-752D3309-2FB9-47F7-B244-E25F24E4FDEBQ34098868-C871CFF9-A563-46FA-B62A-F7A10F83B05DQ34301899-70714CA2-11F3-4459-B021-53038D8C6194Q34815169-41EA2CE1-7327-49B8-B4A2-232665933C52Q35143730-3677CE4E-4CEF-4E1D-9BAB-23E015580F2FQ35182712-E6E29987-A7FE-4320-828D-7370FFC5C3BEQ35948073-4D9B0B10-EFCD-40DE-A4F0-B2FAB1AC0632Q36015423-C9EB97CB-3689-4851-B9CB-A952D40A515FQ36404673-CD29211E-CC38-4456-AA44-FCF9F65D7ABAQ36524357-ADD20C94-587B-450F-8F5B-2B5BAE7CA7E1Q36978847-849D5138-96C8-43DC-A48F-8608F42C1131Q37009811-E323A4A7-BF9A-45AB-8E9F-DD818F604958Q37059821-1F788E06-FE99-40A8-A3BD-2327102A7EECQ37078512-11017003-B81E-4FE3-84AE-1F1B54D4BFF3Q37444317-CBA0C25C-A03B-415C-866A-437A6F1BC435Q39549058-F98E26CB-DFD5-4F8B-9519-62747B136156Q39589096-37E5E19A-1886-40E3-880B-350A25C97F7AQ39596414-DA2D33D4-87BE-4053-95DE-091028DB0BC8Q39611742-C29808D7-907A-4D9D-B5C2-84D83493352AQ39682548-05415F0D-873A-4EF1-B960-B9CB8978541CQ41871764-1254B2D7-66C4-449C-8C0D-DC767A027CD3Q43825794-2A39572E-6F98-43B0-A21A-3A5704DC8588Q55054068-F250E93D-1339-47A9-8000-9399119E38E3
P2860
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Strong human immunodeficiency ...... with nef-defective HIV type 1
@ast
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en-gb
Strong human immunodeficiency ...... with nef-defective HIV type 1
@nl
type
label
Strong human immunodeficiency ...... with nef-defective HIV type 1
@ast
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en-gb
Strong human immunodeficiency ...... with nef-defective HIV type 1
@nl
prefLabel
Strong human immunodeficiency ...... with nef-defective HIV type 1
@ast
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en-gb
Strong human immunodeficiency ...... with nef-defective HIV type 1
@nl
P2093
P2860
P921
P1433
P1476
Strong human immunodeficiency ...... with nef-defective HIV type 1
@en
P2093
A J McMichael
J S Sullivan
M A Demoitie
S L Rowland-Jones
P2860
P304
P407
P577
1999-01-01T00:00:00Z